|
Volumn 10, Issue 8, 2002, Pages 2461-2470
|
6-Carboxy-5,7-diarylcyclopenteno[1,2-b]pyridine derivatives: A novel class of endothelin receptor antagonists
|
Author keywords
[No Author keywords available]
|
Indexed keywords
6 CARBOXY 5 (2 METHOXYPHENYL) 7 (4 METHOXYPHENYL)CYCLOPENTENO[1,2 B]PYRIDINE;
6 CARBOXY 5 (3 METHOXYPHENYL) 7 (4 METHOXYPHENYL)CYCLOPENTENO[1,2 B]PYRIDINE;
6 CARBOXY 5 (3,4 METHYLENEDIOXYPHENYL) 7 PHENYLCYCLOPENTENO[1,2 B]PYRIDINE;
6 CARBOXY 5 (4 METHOXYPHENYL) 7 (3,4 METHYLENEDIOXYPHENYL)CYCLOPENTENO[1,2 B]PYRIDINE;
6 CARBOXY 5 (4 METHOXYPHENYL) 7 (3,4 METHYLENEDIOXYPHENYL)CYCLOPENTENO[1,2 C]PYRIDINE;
6 CARBOXY 5 (INDOL 4 YL) 7 (4 METHOXYPHENYL)CYCLOPENTENO[1,2 B]PYRIDINE;
6 CARBOXY 5 (INDOL 6 YL) 7 (4 METHOXYPHENYL)CYCLOPENTENO[1,2 B]PYRIDINE;
6 CARBOXY 5,7 BIS(4 METHOXYPHENYL)CYCLOPENTENO[1,2 B]PYRIDINE;
6 CARBOXY 7 (2 CARBOXYMETHOXY 4 METHOXYPHENYL) 5 (3,4 METHYLENEDIOXYPHENYL)CYCLOPENTENO[1,2 B]PYRIDINE;
6 CARBOXY 7 (2 HYDROXY 4 METHOXYPHENYL) 5 (3,4 METHYLENEDIOXYPHENYL)CYCLOPENTENO[1,2 B]PYRIDINE;
6 CARBOXY 7 (4 FLUOROPHENYL) 5 (3,4 METHYLENEDIOXYPHENYL)CYCLOPENTENO[1,2 B]PYRIDINE;
6 CARBOXY 7 (4 HYDROXYPHENYL) 5 (3,4 METHYLENEDIOXYPHENYL)CYCLOPENTENO[1,2 B]PYRIDINE;
6 CARBOXY 7 (4 METHOXYPHENYL) 5 (3,4 METHYLENEDIOXYPHENYL)CYCLOPENTENO[1,2 B]PYRIDINE;
6 CARBOXY 7 (4 METHOXYPHENYL) 5 (3,4 METHYLENEDIOXYPHENYL)CYCLOPENTENO[1,2 C]PYRIDINE;
6 CARBOXY 7 (4 METHOXYPHENYL) 5 PHENYLCYCLOPENTENO[1,2 B]PYRIDINE;
6 CARBOXY 7 [2 (2 CARBOXYETHENYL) 4 METHOXYPHENYL] 5 (3,4 METHYLENEDIOXYPHENYL)CYCLOPENTENO[1,2 B]PYRIDINE;
6 CARBOXY 7 [2 (2 CARBOXYETHYL) 4 METHOXYPHENYL] 5 (3,4 METHYLENEDIOXYPHENYL)CYCLOPENTENO[1,2 B]PYRIDINE;
6 CARBOXY 7 [2 (2 HYDROXYETHOXY) 4 METHOXYPHENYL] 5 (3,4 METHYLENEDIOXYPHENYL)CYCLOPENTENO[1,2 B]PYRIDINE;
6 CARBOXY 7 [2 [2 (METHYLAMINO)ETHOXY] 4 METHOXYPHENYL] 5 (3,4 METHYLENEDIOXYPHENYL)CYCLOPENTENO[1,2 B]PYRIDINE;
7 (2 CARBAMOYLMETHOXY 4 METHOXYPHENYL) 6 CARBOXY 5 (3,4 METHYLENEDIOXYPHENYL)CYCLOPENTENO[1,2 B]PYRIDINE;
ENDOTHELIN 1;
ENDOTHELIN A RECEPTOR;
ENDOTHELIN B RECEPTOR;
ENDOTHELIN RECEPTOR ANTAGONIST;
FUNCTIONAL GROUP;
INDAN DERIVATIVE;
IODINE 125;
PHENYL GROUP;
PYRIDINE DERIVATIVE;
UNCLASSIFIED DRUG;
DIAGNOSTIC AGENT;
ENDOTHELIN RECEPTOR;
RADIOACTIVE IODINE;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
ARTICLE;
CELL MEMBRANE;
CONTROLLED STUDY;
DRUG ACTIVITY;
DRUG POTENCY;
DRUG RECEPTOR BINDING;
DRUG SELECTIVITY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
HUMAN;
HUMAN CELL;
IC 50;
ISOTOPE LABELING;
MOUSE;
NEUROBLASTOMA CELL;
NONHUMAN;
PHYSICAL CHEMISTRY;
RAT;
RECEPTOR AFFINITY;
RECEPTOR BLOCKING;
STRUCTURE ACTIVITY RELATION;
STRUCTURE ANALYSIS;
ANIMAL;
DRUG ANTAGONISM;
ILIAC ARTERY;
INTESTINE ABSORPTION;
RABBIT;
SURVIVAL RATE;
SYNTHESIS;
ANIMALS;
HUMANS;
ILIAC ARTERY;
INHIBITORY CONCENTRATION 50;
INTESTINAL ABSORPTION;
IODINE RADIOISOTOPES;
MICE;
PYRIDINES;
RABBITS;
RATS;
RECEPTOR, ENDOTHELIN A;
RECEPTOR, ENDOTHELIN B;
RECEPTORS, ENDOTHELIN;
STRUCTURE-ACTIVITY RELATIONSHIP;
SURVIVAL RATE;
|
EID: 0036285750
PISSN: 09680896
EISSN: None
Source Type: Journal
DOI: 10.1016/S0968-0896(02)00122-0 Document Type: Article |
Times cited : (15)
|
References (24)
|